Tag: hormone receptor-positive breast cancer


UTHSC’s Graetz Receives $2 Million to Study App Benefiting Additional Cancer Therapy for Women

|

Ilana Graetz, PhD, assistant professor in the Department of Preventive Medicine at the University of Tennessee Health Science Center, recently received a $2,021,260 R01 award from the National Institutes of Health (NIH). With her award, Dr. Graetz will examine the use of a novel web-based app designed to improve long-term use of adjuvant endocrine therapy… Read More